{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:25:45Z","timestamp":1769761545522,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00467-020-04744-8","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T04:07:50Z","timestamp":1600488470000},"page":"621-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic plasma exchange: single-center experience in children with kidney disorders"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-4631","authenticated-orcid":false,"given":"Catherine","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poyyapakkam R.","family":"Srivaths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"key":"4744_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jca.21257","volume":"28","author":"AA Kaplan","year":"2013","unstructured":"Kaplan AA (2013) Therapeutic plasma exchange: a technical and operational review. J Clin Apher 28:3\u201310","journal-title":"J Clin Apher"},{"key":"4744_CR2","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","volume":"52","author":"AA Kaplan","year":"2008","unstructured":"Kaplan AA (2008) Therapeutic plasma exchange: core curriculum 2008. Am J Kidney Dis 52:1180\u20131196","journal-title":"Am J Kidney Dis"},{"key":"4744_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/bmj.2.5965.252","volume":"2","author":"CM Lockwood","year":"1975","unstructured":"Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK (1975) Recovery from Goodpasture\u2019s syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 2:252\u2013254","journal-title":"Br Med J"},{"key":"4744_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","volume":"1","author":"CM Lockwood","year":"1976","unstructured":"Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB (1976) Immunosuppression and plasma-exchange in the treatment of Goodpasture\u2019s syndrome. Lancet 1:711\u2013715","journal-title":"Lancet"},{"key":"4744_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","volume":"34","author":"A Padmanabhan","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ (2019) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher 34:171\u2013354","journal-title":"J Clin Apher"},{"key":"4744_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2016.06.009","volume":"90","author":"WF Clark","year":"2016","unstructured":"Clark WF, Huang SS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM (2016) Plasmapheresis for the treatment of kidney diseases. Kidney Int 90:974\u2013984","journal-title":"Kidney Int"},{"key":"4744_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.ackd.2014.01.008","volume":"21","author":"AM Hildebrand","year":"2014","unstructured":"Hildebrand AM, Huang SH, Clark WF (2014) Plasma exchange for kidney disease: what is the best evidence? Adv Chronic Kidney Dis 21:217\u2013227","journal-title":"Adv Chronic Kidney Dis"},{"key":"4744_CR8","doi-asserted-by":"publisher","unstructured":"Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574\u2013581. https:\/\/doi.org\/10.1016\/s0272-6386(12)80381-7","DOI":"10.1016\/s0272-6386(12)80381-7"},{"key":"4744_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","volume":"70","author":"RA Montgomery","year":"2000","unstructured":"Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE (2000) Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70:887\u2013895","journal-title":"Transplantation"},{"key":"4744_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/1744-9987.12430","volume":"20","author":"J Gubensek","year":"2016","unstructured":"Gubensek J, Buturovic-Ponikvar J, Kandus A, Arnol M, Lindic J, Kovac D, Rigler AA, Romozi K, Ponikvar R (2016) Treatment of antibody-mediated rejection after kidney transplantation - 10 years\u2019 experience with apheresis at a single center. Ther Apher Dial 20:240\u2013245","journal-title":"Ther Apher Dial"},{"key":"4744_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.23736\/S0026-4946.16.04152-9","volume":"69","author":"F Paglialonga","year":"2017","unstructured":"Paglialonga F, Ardissino G, Consolo S, Ghio L, Belingheri M, Testa S, Biasuzzi A, Edefonti A (2017) Plasma-exchange in pediatric patients: a single-center experience. Minerva Pediatr 69:113\u2013120","journal-title":"Minerva Pediatr"},{"key":"4744_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/ckj\/sfv084","volume":"8","author":"SK Reddy","year":"2015","unstructured":"Reddy SK, Jahan A, Chaturvedi S, Agarwal I (2015) Plasma exchange for paediatric kidney disease-indications and outcomes: a single-centre experience. Clin Kidney J 8:702\u2013707","journal-title":"Clin Kidney J"},{"key":"4744_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00467-014-2907-3","volume":"30","author":"F Paglialonga","year":"2015","unstructured":"Paglialonga F, Schmitt CP, Shroff R, Vondrak K, Aufricht C, Watson AR, Ariceta G, Fischbach M, Klaus G, Holtta T, Bakkaloglu SA, Zurowska A, Jankauskiene A, Vande Walle J, Schaefer B, Wright E, Connell R, Edefonti A (2015) Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units. Pediatr Nephrol 30:103\u2013111","journal-title":"Pediatr Nephrol"},{"key":"4744_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/TP.0000000000002049","volume":"102","author":"SS Wan","year":"2018","unstructured":"Wan SS, Ying TD, Wyburn K, Roberts DM, Wyld M, Chadban SJ (2018) The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis. Transplantation 102:557\u2013568","journal-title":"Transplantation"},{"key":"4744_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/bmt.2017.207","volume":"53","author":"J Khosla","year":"2018","unstructured":"Khosla J, Yeh AC, Spitzer TR, Dey BR (2018) Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. Bone Marrow Transplant 53:129\u2013137","journal-title":"Bone Marrow Transplant"},{"key":"4744_CR16","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118:1452\u20131462","journal-title":"Blood"},{"key":"4744_CR17","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.transproceed.2009.06.197","volume":"41","author":"CM Brown","year":"2009","unstructured":"Brown CM, Abraham KA, O\u2019Kelly P, Conlon PJ, Walshe JJ (2009) Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation. Transplant Proc 41:3690\u20133692","journal-title":"Transplant Proc"},{"key":"4744_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.transproceed.2009.01.062","volume":"41","author":"AM Gomes","year":"2009","unstructured":"Gomes AM, Pedroso S, Martins LS, Malheiro J, Viscayno JR, Santos J, Dias L, Henriques AC, Sarmento AM, Cabrita A (2009) Diagnosis and treatment of acute humoral kidney allograft rejection. Transplant Proc 41:855\u2013858","journal-title":"Transplant Proc"},{"key":"4744_CR19","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1097\/TP.0000000000002141","volume":"102","author":"E Velidedeoglu","year":"2018","unstructured":"Velidedeoglu E, Cavaille-Coll MW, Bala S, Belen OA, Wang Y, Albrecht R (2018) Summary of 2017 FDA public workshop: antibody-mediated rejection in kidney transplantation. Transplantation 102:e257\u2013e264","journal-title":"Transplantation"},{"key":"4744_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0272-6386(99)70010-7","volume":"34","author":"R Dall\u2019Amico","year":"1999","unstructured":"Dall\u2019Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34:1048\u20131055","journal-title":"Am J Kidney Dis"},{"key":"4744_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ndt\/14.3.564","volume":"14","author":"JD Briggs","year":"1999","unstructured":"Briggs JD, Jones E (1999) Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 14:564\u2013565","journal-title":"Nephrol Dial Transplant"},{"key":"4744_CR22","doi-asserted-by":"publisher","first-page":"e13154","DOI":"10.1111\/petr.13154","volume":"22","author":"PS Verghese","year":"2018","unstructured":"Verghese PS, Rheault MN, Jackson S, Matas AJ, Chinnakotla S, Chavers B (2018) The effect of peri-transplant plasmapheresis in the prevention of recurrent FSGS. Pediatr Transplant 22:e13154","journal-title":"Pediatr Transplant"},{"key":"4744_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/petr.12185","volume":"18","author":"C Straatmann","year":"2014","unstructured":"Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, Carson T, Florman S, Vehaskari MV (2014) Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr Transplant 18:29\u201334","journal-title":"Pediatr Transplant"},{"key":"4744_CR24","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3389\/fimmu.2019.01669","volume":"10","author":"K Kienzl-Wagner","year":"2019","unstructured":"Kienzl-Wagner K, Waldegger S, Schneeberger S (2019) Disease recurrence-the sword of Damocles in kidney transplantation for primary focal segmental glomerulosclerosis. Front Immunol 10:1669","journal-title":"Front Immunol"},{"key":"4744_CR25","doi-asserted-by":"publisher","first-page":"e0196009","DOI":"10.1371\/journal.pone.0196009","volume":"13","author":"E Uechi","year":"2018","unstructured":"Uechi E, Okada M, Fushimi K (2018) Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: a propensity-matched analysis using a nationwide administrative database. PLoS One 13:e0196009","journal-title":"PLoS One"},{"key":"4744_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2015.08.003","volume":"65","author":"G de Luna","year":"2015","unstructured":"de Luna G, Chauveau D, Aniort J, Carron PL, Gobert P, Karras A, Marchand-Adam S, Maurier F, Hatron PY, Mania A, le Guenno G, Bally S, Bienvenu B, Cardineau E, Goulenok T, Jourde-Chiche N, Samson M, Huart A, Pourrat J, Tiple A, Aumaitre O, Puechal X, Heshmati F, le Jeunne C, Mouthon L, Guillevin L, Terrier B, French Vasculitis Study Group (2015) Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: data from the French Vasculitis Study Group. J Autoimmun 65:49\u201355","journal-title":"J Autoimmun"},{"key":"4744_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1053\/j.ajkd.2011.01.005","volume":"57","author":"L Harper","year":"2011","unstructured":"Harper L, Morgan MD (2011) Plasma exchange for severe ANCA-associated vasculitis? Am J Kidney Dis 57:532\u2013535","journal-title":"Am J Kidney Dis"},{"key":"4744_CR28","first-page":"2169","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Jayne DRW (2020) Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. Reply N Engl J Med 382:2169","journal-title":"Reply N Engl J Med"},{"key":"4744_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ki.2013.373","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon-Durey MA, Bagga A, Indian HUS Registry (2014) Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int 85:1151\u20131160","journal-title":"Kidney Int"},{"key":"4744_CR30","doi-asserted-by":"publisher","first-page":"e18308","DOI":"10.1097\/MD.0000000000018308","volume":"98","author":"J Lu","year":"2019","unstructured":"Lu J, Zhang L, Xia C, Tao Y (2019) Complications of therapeutic plasma exchange: a retrospective study of 1201 procedures in 435 children. Medicine (Baltimore) 98:e18308","journal-title":"Medicine (Baltimore)"},{"key":"4744_CR31","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1537-2995.2007.01405.x","volume":"47","author":"B Michon","year":"2007","unstructured":"Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, David M, Duval M, Hume HA, Robitaille N, Belisle A, Champagne MA (2007) Complications of apheresis in children. Transfusion 47:1837\u20131842","journal-title":"Transfusion"},{"key":"4744_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jca.20143","volume":"22","author":"D Shemin","year":"2007","unstructured":"Shemin D, Briggs D, Greenan M (2007) Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 22:270\u2013276","journal-title":"J Clin Apher"},{"key":"4744_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/jca.21594","volume":"33","author":"K Sigler","year":"2018","unstructured":"Sigler K, Lee J, Srivaths P (2018) Regional citrate anticoagulation with calcium replacement in pediatric apheresis. J Clin Apher 33:274\u2013277","journal-title":"J Clin Apher"},{"key":"4744_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2215\/CJN.07010618","volume":"14","author":"A Adwaney","year":"2019","unstructured":"Adwaney A, Lim C, Blakey S, Duncan N, Ashby DR (2019) Central venous stenosis, access outcome and survival in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol 14:378\u2013384","journal-title":"Clin J Am Soc Nephrol"},{"key":"4744_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0036-1572547","volume":"33","author":"PR Bream Jr","year":"2016","unstructured":"Bream PR Jr (2016) Update on insertion and complications of central venous catheters for hemodialysis. Semin Intervent Radiol 33:31\u201338","journal-title":"Semin Intervent Radiol"},{"key":"4744_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ndt\/6.10.722","volume":"6","author":"F Schillinger","year":"1991","unstructured":"Schillinger F, Schillinger D, Montagnac R, Milcent T (1991) Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 6:722\u2013724","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04744-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04744-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:50:35Z","timestamp":1632012635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04744-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4744"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04744-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB approval was obtained, and we certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}